1. Home
  2. VRDN
  3. VRDN News

Latest Viridian Therapeutics Inc. (VRDN) News on July 26, 2024

Viridian Therapeutics Announces Completion of THRIVE-2 Enrollment for VRDN-001 in Patients with Chronic Thyroid Eye Disease (TED)

Business Wire

a day ago

Viridian Therapeutics Announces Completion of THRIVE-2 Enrollment for VRDN-001 in Patients with Chronic Thyroid Eye Disease (TED)

Share on Social Networks: